Cancer-associated myositis in Chinese patients with idiopathic inflammatory myopathies: Malignancy spectrum, risk factors, and validation of the IMACS guideline
Cancer-associated myositis in Chinese patients with idiopathic inflammatory myopathies: Malignancy spectrum, risk factors, and validation of the IMACS guideline. // Seminars in Arthritis and Rheumatism. – URL: https://www.sciencedirect.com/science/article/pii/S0049017226001459?dgcid=rss_sd_all
Cancer-associated myositis in Chinese patients with idiopathic inflammatory myopathies: Malignancy spectrum, risk factors, and validation of the IMACS guideline. Seminars in Arthritis and Rheumatism. https://www.sciencedirect.com/science/article/pii/S0049017226001459?dgcid=rss_sd_all
“Cancer-associated myositis in Chinese patients with idiopathic inflammatory myopathies: Malignancy spectrum, risk factors, and validation of the IMACS guideline.” Seminars in Arthritis and Rheumatism.
@article{article117683,
title = {Cancer-associated myositis in Chinese patients with idiopathic inflammatory myopathies: Malignancy spectrum, risk factors, and validation of the IMACS guideline},
journal = {Seminars in Arthritis and Rheumatism},
url = {https://www.sciencedirect.com/science/article/pii/S0049017226001459?dgcid=rss_sd_all}
}